MedKoo Biosciences, Inc.
Tel:   +1-919-636-5577    Fax:   +1-919-980-4831    Email:   sales@medkoo.com
Search
Login Register
Search
MedKoo Cat#: 596769 | Name: Bilanafos

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Bilanafos is an Anti-Bacterial Agent.

Chemical Structure

Bilanafos
Bilanafos
CAS#35597-43-4 (free acid)

Theoretical Analysis

MedKoo Cat#: 596769

Name: Bilanafos

CAS#: 35597-43-4 (free acid)

Chemical Formula: C11H22N3O6P

Exact Mass: 323.1246

Molecular Weight: 323.28

Elemental Analysis: C, 40.87; H, 6.86; N, 13.00; O, 29.69; P, 9.58

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
35597-43-4 (free acid) 71048-99-2 (sodium)
Synonym
Bilanafos; Bialaphos; Herby; Antibiotic SF 1293; SF1293; SF-1293
IUPAC/Chemical Name
(2-amino-4-((hydroxymethyl)hydrophosphoryl)butanoyl)-L-alanyl-L-alanine
InChi Key
VGEZOZJJXPKDEJ-WPZUCAASSA-N
InChi Code
InChI=1S/C11H22N3O6P/c1-6(9(16)14-7(2)11(18)19)13-10(17)8(12)3-4-21(20)5-15/h6-8,15,21H,3-5,12H2,1-2H3,(H,13,17)(H,14,16)(H,18,19)/t6-,7-,8?/m0/s1
SMILES Code
C[C@@H](C(O)=O)NC([C@H](C)NC(C(N)CCP(CO)=O)=O)=O
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 323.28 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Bilanakis N, Vratsista A, Siorou S. A brain ependymoma with psychiatric manifestation. J BUON. 2017 Nov-Dec;22(6):1604-1605. PubMed PMID: 29332363. 2: Bilanakis N, Peritogiannis VK, Vratsista A. Treatment decision-making capacity in hospitalized patients with schizophrenia. Psychiatriki. 2017 Jan-Mar;28(1):37-45. doi: 10.22365/jpsych.2017.281.37. PubMed PMID: 28541237. 3: Hargarter L, Bergmans P, Cherubin P, Keim S, Conca A, Serrano-Blanco A, Bitter I, Bilanakis N, Schreiner A. Once-monthly paliperidone palmitate in recently diagnosed and chronic non-acute patients with schizophrenia. Expert Opin Pharmacother. 2016 Jun;17(8):1043-53. doi: 10.1080/14656566.2016.1174692. Epub 2016 May 9. PubMed PMID: 27042990; PubMed Central PMCID: PMC4898156. 4: Bilanakis N, Vratsista A, Athanasiou E, Niakas D, Peritogiannis V. Medical patients' treatment decision making capacity: a report from a general hospital in Greece. Clin Pract Epidemiol Ment Health. 2014 Nov 26;10:133-9. doi: 10.2174/1745017901410010133. eCollection 2014. PubMed PMID: 25505489; PubMed Central PMCID: PMC4260233. 5: Bilanakis N, Vratsista A, Kalampokis G, Papamichael G, Peritogiannis V. The Greek version of the MacArthur competence assessment tool for treatment: reliability and validity. Evaluation of capacity for treatment decisions in Greek psychiatric patients. Ann Gen Psychiatry. 2013 Apr 9;12(1):10. doi: 10.1186/1744-859X-12-10. PubMed PMID: 23570333; PubMed Central PMCID: PMC3648422. 6: Bilanakis N. [Compulsory hospitalization: α case of conflict between the psychiatrist and the persecutor due to the obscurity of the law]. Psychiatriki. 2012 Jul-Sep;23(3):255-61. Greek, Modern. PubMed PMID: 23073548. 7: Bilanakis N, Papamichael G, Peritogiannis V. Chemical restraint in routine clinical practice: a report from a general hospital psychiatric ward in Greece. Ann Gen Psychiatry. 2011 Feb 24;10:4. doi: 10.1186/1744-859X-10-4. PubMed PMID: 21349171; PubMed Central PMCID: PMC3050779. 8: Bilanakis N, Kalampokis G, Christou K, Peritogiannis V. Use of coercive physical measures in a psychiatric ward of a general hospital in Greece. Int J Soc Psychiatry. 2010 Jul;56(4):402-11. doi: 10.1177/0020764009106620. Epub 2009 Jul 23. PubMed PMID: 19628555. 9: Bilanakis N, Peritogiannis V. Attitudes of patients and families toward restraint and seclusion. Psychiatr Serv. 2008 Oct;59(10):1220. doi: 10.1176/appi.ps.59.10.1220. PubMed PMID: 18832516. 10: Bilanakis N, Peritogiannis V, Kalampokis G. Infections as complications of neuroleptic malignant syndrome. World J Biol Psychiatry. 2009;10(4 Pt 3):973-6. doi: 10.1080/15622970801935578. PubMed PMID: 18609425. 11: Geitona M, Ollandezos M, Kousoulakou C, Agelopoulos E, Zaharakis K, Kakavas P, Karpouza B, Kesidou S, Bilanakis N, Papamichael E, Papanicolaou S, Chaidemenos A, Chamogeorgakis T, Kyriopoulos J. [The cost of treating schizophrenia in Greece]. Psychiatriki. 2007 Jan;18(1):47-58. Greek, Modern. PubMed PMID: 22466429. 12: Bilanakis N. Psychogenic urinary retention. Gen Hosp Psychiatry. 2006 May-Jun;28(3):259-61. PubMed PMID: 16675372. 13: Bilanakis N, Gibiriti M. Lithium intoxication, hypercalcemia and "accidentally" induced food and water aversion: a case report. Prog Neuropsychopharmacol Biol Psychiatry. 2004 Jan;28(1):201-3. PubMed PMID: 14687875. 14: Bilanakis N, Madianos MG, Liakos A. Psychiatric morbidity among repatriated Greek migrants in a rural area. Eur Arch Psychiatry Clin Neurosci. 1995;245(1):36-44. PubMed PMID: 7786910.

View History

Bisdionin F

Bisdionin F

Bishydroxyethyl dihydroxypropyl stearammonium chloride

Bishydroxyethyl dihydroxypropyl stearammonium chloride

PNU-248686A

PNU-248686A

PNU-168754

PNU-168754

PNU-177553

PNU-177553